Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 48
Structure and inhibition of SARS-CoV-2 spike refolding in membranes
Michael W. Grunst, Zhuan Qin, Esteban Dodero‐Rojas, et al.
Science (2024) Vol. 385, Iss. 6710, pp. 757-765
Closed Access | Times Cited: 17
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Semisynthesis of homogeneous spike RBD glycoforms from SARS-CoV-2 for profiling the correlations between glycan composition and function
Farong Ye, Cheng Li, Feng‐Liang Liu, et al.
National Science Review (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 12
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 11
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike
Timothy J.C. Tan, Abhishek Kumar Verma, Abby Odle, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 9
Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice
Peter Halfmann, Raj S. Patel, Kathryn Loeffler, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
Ying Lu, An‐Qi Li, Fan Shen, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 1
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 19
A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants
Xuefan Wu, Wei Li, Heng Rong, et al.
ACS Nano (2024) Vol. 18, Iss. 27, pp. 17749-17763
Closed Access | Times Cited: 8
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
Self-assembled ferritin-based nanoparticles elicit a robust broad-spectrum protective immune response against SARS-CoV-2 variants
Weiqi Wang, Xianyong Meng, Huan Cui, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130820-130820
Closed Access | Times Cited: 7
Overview of the recent advances in porcine epidemic diarrhea vaccines
Miaozhan Wei, Lan Chen, Rong Zhang, et al.
The Veterinary Journal (2024) Vol. 304, pp. 106097-106097
Closed Access | Times Cited: 6
Discovery and characterization of a pan-betacoronavirus S2-binding antibody
Nicole V. Johnson, Steven C. Wall, Kevin J. Kramer, et al.
Structure (2024)
Closed Access | Times Cited: 6
Combining Phage Display Technology with In Silico -Designed Epitope Vaccine to Elicit Robust Antibody Responses against Emerging Pathogen Tilapia Lake Virus
Yu‐Ming Gong, Xuefeng Wei, Yuying Zheng, et al.
Journal of Virology (2023) Vol. 97, Iss. 4
Open Access | Times Cited: 16
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus
Dan Yang, Xinglin Wang, Xu Yang, et al.
Virology (2024) Vol. 596, pp. 110113-110113
Closed Access | Times Cited: 5
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Jamie Guenthoer, Meghan Garrett, Michelle M. Lilly, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012383-e1012383
Open Access | Times Cited: 5
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
Kimia Sobhani, Susan Cheng, Raquel A. Binder, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1644-1644
Open Access | Times Cited: 13
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
Xinling Wang, Lujia Sun, Zezhong Liu, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 12
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection
Fan Zhou, Juha Vahokoski, Siri Øyen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Enhancing vaccine half-life as a novel strategy for improving immune response durability of subunit vaccines
Zhaoling Shen, Cheng Li, Wenping Song, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012845-e1012845
Open Access
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques
Hélène Letscher, Delphine Guilligay, Grégory Effantin, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 10
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
Page 1 - Next Page

Scroll to top